Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Surgical Sealants, Inc. Hoping To Debut SurgiSeal Vascular Sealant In 2000

This article was originally published in The Gray Sheet

Executive Summary

Development stage Surgical Sealants, Inc. is currently conducting clinical trials of its collagen-based SurgiSeal vascular sealant and expects to submit a 510(k) to FDA by year-end.
Advertisement

Related Content

In Brief: Bio-Vascular
FUSION MEDICAL TECHNOLOGIES RAPISEAL 510(k) FILED IN APRIL, FIRM SAYS IN PROSPECTUS; 96% EFFECTIVENESS RATE IN LUNG RESECTION PATIENTS SHOWN IN CLINICALS
FUSION MEDICAL TECHNOLOGIES RAPISEAL 510(k) FILED IN APRIL, FIRM SAYS IN PROSPECTUS; 96% EFFECTIVENESS RATE IN LUNG RESECTION PATIENTS SHOWN IN CLINICALS
Advertisement
UsernamePublicRestriction

Register

MT012211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel